Latest News

Exclusive Interviews

Browse by Company

  • All
  • AIkido Pharma
  • Aion Therapeutic
  • Albert Labs
  • Aleafia Health
  • Algernon Pharmaceuticals
  • Alphamind
  • Atai Life Sciences
  • Atma Journeys
  • AWAKN
  • Beckley Psytech
  • Better Plant Sciences
  • BetterLife Pharma
  • Bexson Biomedical
  • Braxia Scientific
  • Bright Minds Biosciences
  • Brightmind
  • Buzz Capital
  • CaaMTech
  • CannaGlobal Wellness
  • CB Therapeutics
  • CBDV
  • Champignon Brands
  • Clerkenwell Health
  • Compass Pathways
  • Cybin Corp
  • Delic Corp
  • Delix Therapuetics
  • DemeRx
  • Diamond Therapeutics
  • Ehave
  • Ei Foundation
  • Ei Ventures
  • Eleusian Biosciences
  • Eleusis
  • Empower Clinics
  • Entheon Biomedical
  • Entheos Foundation
  • Field Trip Health
  • Filament Health
  • Fireside Project
  • GH Research
  • GreenStar Biosciences
  • Havn Life
  • Hollister Biosciences
  • IntelGenx
  • Levitee Labs
  • Liberty Leaf
  • Lobe Sciences
  • MagicMed
  • MAPS
  • Mind Cure
  • Mindleap
  • MindMed
  • Mindset Pharma
  • Mota Ventures
  • Mycrodose Therapeutics
  • Mydecine
  • MYND Life Sciences
  • NeonMind
  • New Wave
  • NewLeaf Brands
  • Noetic Foundry
  • Nova Mentis
  • Nova Mentis Biotech
  • Novamind
  • Numinus
  • Nutritional High
  • NYU Langone Health
  • Octarine Bio
  • Optimi Health
  • Orthogonal Thinker
  • Osmond Labs
  • Osoyoos
  • Pharmadrug
  • Pharmather
  • Pilz Bioscience
  • PSFC
  • Psilera Bioscience
  • PsyBio
  • Psyched Wellness
  • Psyence Group
  • Psygen
  • PSYK
  • Pure Extracts
  • Red Light Holland
  • Reset Pharma
  • Revive Therapeutics
  • Silo Pharma
  • Silo Wellness
  • Small Pharma
  • SYNTAC Institute
  • Synthesis Institute
  • The Lundquist Institute
  • TheraPsil
  • Thoughtful Brands
  • Tryp Therapeutics
  • Unlimited Sciences
  • Usona Institute
  • Wesana Health
  • Wuhan General Group
  • Yield Growth Corp
All
  • All
  • AIkido Pharma
  • Aion Therapeutic
  • Albert Labs
  • Aleafia Health
  • Algernon Pharmaceuticals
  • Alphamind
  • Atai Life Sciences
  • Atma Journeys
  • AWAKN
  • Beckley Psytech
  • Better Plant Sciences
  • BetterLife Pharma
  • Bexson Biomedical
  • Braxia Scientific
  • Bright Minds Biosciences
  • Brightmind
  • Buzz Capital
  • CaaMTech
  • CannaGlobal Wellness
  • CB Therapeutics
  • CBDV
  • Champignon Brands
  • Clerkenwell Health
  • Compass Pathways
  • Cybin Corp
  • Delic Corp
  • Delix Therapuetics
  • DemeRx
  • Diamond Therapeutics
  • Ehave
  • Ei Foundation
  • Ei Ventures
  • Eleusian Biosciences
  • Eleusis
  • Empower Clinics
  • Entheon Biomedical
  • Entheos Foundation
  • Field Trip Health
  • Filament Health
  • Fireside Project
  • GH Research
  • GreenStar Biosciences
  • Havn Life
  • Hollister Biosciences
  • IntelGenx
  • Levitee Labs
  • Liberty Leaf
  • Lobe Sciences
  • MagicMed
  • MAPS
  • Mind Cure
  • Mindleap
  • MindMed
  • Mindset Pharma
  • Mota Ventures
  • Mycrodose Therapeutics
  • Mydecine
  • MYND Life Sciences
  • NeonMind
  • New Wave
  • NewLeaf Brands
  • Noetic Foundry
  • Nova Mentis
  • Nova Mentis Biotech
  • Novamind
  • Numinus
  • Nutritional High
  • NYU Langone Health
  • Octarine Bio
  • Optimi Health
  • Orthogonal Thinker
  • Osmond Labs
  • Osoyoos
  • Pharmadrug
  • Pharmather
  • Pilz Bioscience
  • PSFC
  • Psilera Bioscience
  • PsyBio
  • Psyched Wellness
  • Psyence Group
  • Psygen
  • PSYK
  • Pure Extracts
  • Red Light Holland
  • Reset Pharma
  • Revive Therapeutics
  • Silo Pharma
  • Silo Wellness
  • Small Pharma
  • SYNTAC Institute
  • Synthesis Institute
  • The Lundquist Institute
  • TheraPsil
  • Thoughtful Brands
  • Tryp Therapeutics
  • Unlimited Sciences
  • Usona Institute
  • Wesana Health
  • Wuhan General Group
  • Yield Growth Corp
Weekly Psychedelic Bulletin
Psychedelic Investment Bulletin

Psychedelic Bulletin: Are REMS Patents the Next Frontier in the Psychedelics Patent Skirmish? Johns Hopkins Researcher Scores U.S. Government Grant

PharmaTher PR
Press Release

PharmaTher Announces CAD$10 Million Private Placement With Institutional Investors

Levitee Labs PR
Press Release

Levitee Labs Announces DTC Eligibility Approval

Awakn Life Sciences News
Press Release

Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London

Numinus Press Release
Press Release

Numinus Completes Acquisition of Neurology Centre of Toronto

MindMed News
Press Release

MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration

ATMA Journey Centers
Press Release

ATMA Journey Centers Offer Regulated Health Care Professionals a Means to Incorporate Psychedelic-Assisted Psychotherapy Into Their Practice

Mind Cure Psychedelic Company
Press Release

MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers